Skip to main content

Grafa News and Videos — Page 1105

Grafa Headlines

Latest

Grafa

Fractyl Health reports positive one-year weight maintenance results in Revita study

Fractyl Health (NASDAQ:GUTS) today announced positive one-year, open-label results from its REVEAL-1 study, which evaluated the Revita® duodenal mucosal resurfacing procedure in patients who had discontinued the use of GLP-1 receptor agonist medications.

Read more: Fractyl Health reports positive one-year weight maintenance results in Revita study

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift